InsidersTradesSigma
Apotea AB (publ): directors' dealings · Finland · FIN-FSA
FI:apotea-ab-publ-2346ddSE0023313762FI·FIN-FSAMcap 7.9Bn€Healthcare
Explore the full management transaction log of Apotea AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Apotea AB (publ) has logged 4 insider filings. Market capitalisation: €7.9bn. The latest transaction was filed on 4 February 2026 — Purchase. Among the most active insiders: Pär Svärdson. All data is openly available.
4
Insider Decl.
0
Thresholds
€3m
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
75.65 €
Analyst consensus
2 analysts80.00 €Target 90.00 €(+19%)100.00 €
Income statement
Revenue7.20 Bn€
Gross profit1.94 Bn€27% margin
Net income228.7 M€3.2% margin
Valuation
PER (trailing)33.3x
PER (forward)21.3x
P/Book8.5x
Balance sheet & cash
Market cap7.87 Bn€
Total debt331.0 M€
Free Cash Flow117.7 M€
Debt / Equity31%
Profitability & ownership
ROE28.3%
ROA9.4%
% insiders42.2%
% institutions56.4%
Last declaration on 4 February 2026
Declarations4 total
Executives●Purchase35FIN-FSA
€3m475,000 shares@ €5.93450.036% mcap85.6% of flow
Aktie
FI:A003V639-1·
Ideal exit: 1 Nov 2026 (T+270)
Executives●Purchase16FIN-FSA
€17,6473,000 shares@ €5.88230.0002% mcap100.0% of flow
Aktie
FI:A003V632-1·
Ideal exit: 1 Nov 2026 (T+270)
Executives●Purchase24FIN-FSA
€474,62381,000 shares@ €5.85950.0060% mcap14.4% of flow
Aktie
FI:A003V617-1·
Ideal exit: 1 Nov 2026 (T+270)
Executives●Purchase16FIN-FSA
€21436 shares@ €5.93730.0000% mcap100.0% of flow
Aktie
FI:A003V625-1·
Ideal exit: 1 Nov 2026 (T+270)
4 of 4 declarations